U.S. Direct-to-Consumer Genetic Testing Market Size By Test Type (Carrier Testing, Predictive Testing, Ancestry & Relationship Testing, Nutrigenomics Testing), By Technology (Targeted Analysis, Single Nucleotide Polymorphism (SNP) Chips, Whole Genome Sequencing (WGS)), Industry Analysis Report, Application Potential, Competitive Market Share & Forecast, 2019 – 2025
Published Date: Sep 2019 | Report ID: GMI4368 | Authors: Sumant Ugalmugle
U.S. Direct-to-Consumer Genetic Testing Market size was valued at USD 299.4 million in 2018 and is expected to witness 14.7% CAGR from 2019 to 2025. In addition, the volume of direct-to-consumer genetic testing kits is set to exceed 11,000 thousand units by 2025.
Get more details on this report - Request Free Sample PDF
Growing public awareness regarding genetic disorders and availability of technologically advanced direct-to-consumer genetic testing kits will be a high impact rendering factor for industry growth in near future. Also, several campaigns undertaken by industry players and government have made people aware regarding benefits of early diagnosis. Direct-to-consumer genetic testing require minimum intervention of healthcare professionals and is efficient in providing access to individual’s genetic makeup that further assists in treating ailments. Aforementioned factors will positively stimulate the demand for the U.S. market over the forecast period.
Increasing prevalence of genetic disorders in will prove beneficial for U.S. direct-to-consumer genetic testing market growth over the analysis timeframe. Genetic disorders such as Alzheimer’s, Parkinson’s disorder and cancer are one of the leading ailments causing adverse effects on an individual’s health in the U.S. Direct access to genetic testing enables patients to recognise chances of acquiring various genetic diseases. Thus, pivotal role of direct-to-consumer genetic testing kits in identifying genetic mutations will rise its adoption that in turn will accelerate its demand. However, high cost of direct-to-consumer genetic testing kits may obstruct market growth to certain extent.
|Base Year:||2018||Market Size in 2018:||299.4 Million (USD)|
|Historical Data for:||2014 to 2018||Forecast Period:||2019 to 2025|
|Forecast Period 2019 to 2025 CAGR:||14.7%||2025 Value Projection:||890 Million (USD)|
|Pages:||56||Tables, Charts & Figures:||12|
|Segments covered:||Test Type, Technology and Region|
|Companies covered (12):||3andMe, Inc., Ancestry, Color Genomics, Easy DNA, FamilytreeDNA (Gene By Gene), Full Genome Corporation Inc., Helix OpCo LLC, Identigene, Inc., Karmagenes SA, Living DNA Ltd., MyHeritage Ltd., Pathway genomics|
|Pitfalls & Challenges:||
U.S. Direct-to-Consumer Genetic Testing Market, By Test Type
Nutrigenomics testing segment of the U.S. market held around USD 60 million in 2018 and is anticipated to grow substantially by 2025. Nutrigenomic testing is used to know the interaction amongst genome and nutrients at molecular level. Moreover, it enables in detecting individual’s response to foods, beverages and supplements that assists patients to consume personalized diet. DTC nutrigenomics testing has crucial role in helping obese people to manage their body metabolism and weight control, thereby favouring segment growth.
Carrier testing segment of the U.S. direct-to-consumer genetic testing market is projected to show around 16% CAGR over the analysis period. Carrier testing is used to identify if a person is a carrier of specific autosomal recessive diseases. Carrier testing is often used by people planning for pregnancy that enable them to detect risks of their offspring inheriting genetic disorders. Thus, growing concern amongst people in analysing their own genetic makeup will fuel segment growth in forthcoming future.
U.S. Direct-to-Consumer Genetic Testing Market, By Technology
Targeted analysis segment of U.S. direct-to-consumer genetic testing market was valued for more than USD 110 million in 2018 and it is anticipated to witness significant growth in coming years. Targeted analysis identifies the defects or the mutations in the genes that result in specific genetic disease. It effectively measures an individual’s genetic makeup that encodes crucial information required for detecting several ailments. Apart from benefits gained through targeted analysis, it delivers results in lesser cost as compared to the rest of alternatives available in the market. Above mentioned factors will augment demand for targeted analysis thereby propelling segment growth.
Whole genome sequencing (WGS) segment of the U.S. market is anticipated to witness more than 14% CAGR throughout the analysis timeframe. WGS enables detection of the entire genome sequence of an individual and helps in identification, characterization and mutation of disease progression. Moreover, it helps in tracking disease outbreaks and also delivers abundant data in minimum time to support assembling of novel genomes. Thus, potential to produce large volumes with the help of WGS for genomics research will boost the segment growth.
Get more details on this report - Request Free Sample PDF
Competitive Market Share
Some of the notable players operating in the U.S. direct-to-consumer genetic testing market include 23andMe, Ancestry.com, Color Genomics, EasyDNA, FamilytreeDNA, Full Genome, Helix OpCo, Identigene, Karmagenes, Living DNA, MyHeritage and Pathway Genomics. These industry players are implementing various strategic initiatives such as product launch, geographical expansion, joint ventures, mergers and acquisitions, etc. Such strategic initiatives help companies to sustain market competition and grab higher revenue share.
Recent industry developments:
- In December 2018, MyHeritage announced partnership with Project Life by Becky Higgins to launch MyHeritage family discovery test to find and record DNA matches for future generations. This partnership will allow company to increase its product portfolio.
- In November 2018, Ancestry announced launch of AncestryDNA Traits, a new product that helps to explore traits and attributes inherited from ancestors. This will help company to expand its customer base in global DTC genetic testing market.
U.S. Direct-to-Consumer Genetic Testing Industry Background
U.S. Direct-to-consumer genetic testing market can be traced back to early 2000’s. Initially, direct-to-consumer genetic testing kits were assumed as to be convenient as they could enable patients to access to their genetic makeup without intervention of healthcare professionals. Even though, direct-to-consumer genetic testing kits had abundant advantages, they were stringently regulated. Regulatory bodies framed stringent regulations to ensure defect free direct-to-consumer genetic testing kits since its commercialization. Recently, there has been change in regulatory scenario and companies have started receiving approvals for products. Stringent framework has resulted in development of defects free kits that can be easily relied. The U.S. Direct-to-consumer genetic testing industry has boomed since past decade due to high adoption and affordability in the country.
Why Global Market Insights, Inc.?
- GMI is unparalleled when to comes to the quality of research and information provided to clients. Our unique methodology is designed to ensure a minimum of 90% accuracy to give our clients excellent value on their investment.
Over 200 experts are available across various time-zones, ready to serve clients for their research needs. Our industry experts help clients to design reports customized to their needs.
An interactive business analytics platform; designed to assist clients in accessing and analyzing market data on real-time basis.Start Your Free Trial